MDElliottMD: home-claude category backfill (parser-claude gap closure)

2026-05-23T10:43:39Z

home-claude category backfill (parser-claude gap closure)

← Older revision		Revision as of 10:43, 23 May 2026
Line 21:		Line 21:
	== References ==		== References ==
	<references />		<references />
			[[Category:Penicillins]]
			[[Category:Beta-lactam antibiotics]]

MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #248

2026-05-23T04:04:21Z

parser-claude batch MedTemplate pre-fill, Top 300 #248

New page

{{MedTemplate
| generic = Penicillin V (phenoxymethylpenicillin)
| brand = Pen-V, Veetids (mostly generic)
| structure =
| classes = [[:Category:Penicillins|Penicillin (natural, narrow-spectrum)]], [[:Category:Beta-lactam_antibiotics|β-lactam antibiotic]]
| uses = <vote slug="strep-pharyngitis-use">Streptococcal pharyngitis</vote>, <vote slug="rheumatic-fever-prophylaxis-use">Rheumatic fever secondary prophylaxis</vote>, <vote slug="dental-prophylaxis-use">Dental procedural prophylaxis (when appropriate)</vote>, <vote slug="postsplenectomy-prophylaxis-use">Post-splenectomy pneumococcal prophylaxis (children)</vote>, <vote slug="erysipelas-use">Erysipelas / cellulitis (penicillin-susceptible)</vote>
| starting_dose = 250-500 mg PO every 6-8 hours
| preparations = 250 mg, 500 mg tablets; 125 mg/5 mL, 250 mg/5 mL suspension
| fda_max = 2 g/d typical
| pill_id =
| routes = Oral
| onset = Hours
| duration = 6-8 hours
| halflife = ~30-60 minutes<ref name="penv-label">FDA Prescribing Information, Pen-V (penicillin V potassium), Eon, current revision. https://www.accessdata.fda.gov/drugsatfda_docs/label/2008/050442s019lbl.pdf</ref>
| bioavailability = ~60% (oral; phenoxymethyl modification makes it acid-stable, unlike penicillin G which is destroyed by gastric acid)<ref name="penv-label" />
| pregnancy = Generally considered safe; widely used.{{citation needed}}
| legal = [[USLegal:Prescription only|Rx-only]] in US
| mechanism = <vote slug="penicillin-v-mech-claim">Penicillin V binds penicillin-binding proteins (PBPs), inhibiting transpeptidation of peptidoglycan cross-links and producing osmotic lysis of growing organisms.</vote> Acid-stable oral natural penicillin with retained activity against Group A Streptococcus, oral streptococci, and Treponema; narrow-spectrum profile preserves microbiome and remains the first-line for confirmed strep pharyngitis because of demonstrated long-term effectiveness, low cost, and avoidance of broader-spectrum collateral damage<ref name="penv-label" />.
}}

== References ==
<references />

Penicillin V - Revision history

MDElliottMD: home-claude category backfill (parser-claude gap closure)

MDElliottMD: parser-claude batch MedTemplate pre-fill, Top 300 #248